Could It Be Time To Sell Iofina plc, Tungsten Corp PLC And RM2 International SA?

As Iofina plc (LON: IOF), Tungsten Corp PLC(LON: TUNG) and RM2 International SA (LON: RM2) plummet, is it time to sell?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Tungsten (LSE: TUNG) and RM2 (LSE: RM2) are both falling this morning after the two companies issued interim trading updates. Pallet producer RM2’s trading update was the more disappointing of the two, and the market has reacted accordingly, sending the company’s shares down by as much as 30% in early trading. And it’s clear why the market has reacted in this way.

Based on feedback from customers, RM2 has decided to change the design of its pallets. Specifically, management has decided to change the friction coating method from powder coating to a gel-based system. This change has been made to address customers’ health, hygiene and safety needs as well as bringing efficiencies and cost savings to the manufacturing process.

However, while this change should benefit the company over the long term, RMs short-term production will take a hit. As a result, revenue and production numbers for the full year will be significantly below previous guidance. 

City analysts had been expecting RM2 to report revenues of £12.3m for 2015 and a pre-tax loss of £8.1m before breaking even during 2016. Production delays are likely to mean that it will now take longer for RM2 to generate a profit.

Still, demand for RM2’s pallets remains high and the group had $83m in cash at the end of 2014. So, there’s no clear reason to sell up just yet. 

Moving in the right direction 

The market has also reacted negatively to Tungsten’s relatively upbeat trading statement issued today. In a statement issued ahead of the company’s annual meeting, management revealed revenues were up 20% year-on-year during the first four months of the financial year. What’s more, all other key performance indicators seemed to be moving in the right direction.

Two new buyers had contracted to join the Tungsten Network in the period, and six existing buyers agreed contract renewals, at an average expected fee increase of 22%. Nearly 7,000 net additional e-invoicing suppliers were activated in the four-month period. 238 suppliers are now registered to use Tungsten Early Payment with 89 live.

After raising £17.5m earlier this year, Tungsten’s management believes that the company has sufficient cash resources to be able to deliver its current strategy. Management made the same statement a few months before the June capital raising. 

City analysts are expecting Tungsten to report a pre-tax loss of £18.3m for 2016 and a pre-tax loss of £5.3m for 2017. Based on these forecasts, Tungsten’s cash balance might not last long. 

Bright prospects 

Iofina’s (LSE: IOF) shares have slumped by more than 50% year-to-date, against the backdrop of challenging iodine market, where prices are below historical trends. Nevertheless, management has reacted quickly to the challenging environment by slashing costs and ramping up production.  

And thanks to these actions City analysts expect Iofina to report its maiden profit this year. Analysts are expecting a pre-tax profit of £0.1m for full-year 2015 on revenues of £16.8m. Earnings per share are expected to jump 641% during 2016 to 1.53p and on this basis Iofina is trading at a 2016 P/E of 12.5. If the company can meet these forecasts, it could be a great play for growth investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Is now the right time for me to buy revived FTSE national institution Marks and Spencer?

Marks and Spencer was once a revered FTSE 100 firm, but poor decisions led to its demotion in 2019. Now…

Read more »

Market Movers

Up 11% today, can this FTSE 250 stock finally get motoring?

Jon Smith explains why the Aston Martin share price has jumped this morning, but urges caution after he picks apart…

Read more »

Investing Articles

With £456m of net cash, FTSE 100 stock easyJet’s ready for take-off

Our writer's been positive on this FTSE 100 for some time, but these Q3 results and its growing cash pile…

Read more »

A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
Investing Articles

Primary Health Properties: a FTSE 250 REIT with a 6% yield, a growing dividend, and a positive outlook

After its latest results show rental income growth, Stephen Wright's looking to buy a FTSE 250 REIT set to benefit…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »